NCT05316103
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since May 2023); last known: Recruiting
- Minor Secondary endpoints: details revised at 1 of 2 entries
- Study description expanded, about 1 word
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Accuracy of pCLE-targeted optical biopsy
Timeframe: 7 days
Secondary (2)
Sensitivity,specificity,positive predictive value and negative predictive value of pCLE targeted optical biopsy
Complications of biopsy
Arms and interventions
Endoscopic biopsy and probe-based confocal laser endomicroscopy biopsyExperimental
In this study , endoscopic biopsy and pCLE-targeted optical biopsy will be successively performed for local rectal scars in rectal cancer patients after neoadjuvant chemoradiotherapy.
Devices: Probe-based confocal laser endomicroscopy targeted optical biopsy
Sites
1 site in 1 country
- Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, China